Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome.
Rajeevan, Mangalathu S, Dimulescu, Irina, Murray, Janna et al. · Human immunology · 2015 · DOI
Quick Summary
Researchers compared the genes of 50 people with ME/CFS to 121 healthy people to look for differences in genes related to immune system and inflammation. They found 32 genetic differences associated with ME/CFS, particularly in genes controlling how the body's natural defense system works. These findings suggest that problems with immune activation may play a role in ME/CFS.
Why It Matters
This study provides genetic evidence supporting the hypothesis that abnormal innate immune activation—particularly in complement and toll-like receptor pathways—may contribute to ME/CFS pathophysiology. Understanding the genetic basis of immune dysfunction could eventually lead to better diagnostic tests and targeted treatments for ME/CFS patients.
Observed Findings
32 functionally important SNPs associated with CFS across immune/inflammation pathways
Genetic predisposition to immune dysregulation may be an important factor in ME/CFS etiology
Remaining Questions
Do these genetic variants actually cause immune dysfunction, or are they markers of other causal mechanisms?
How do these genetic associations translate to the abnormal immune activation and inflammation observed in CFS patients?
What This Study Does Not Prove
This study does not prove that these genetic variants cause ME/CFS; it only shows association in a small sample. The findings are correlational and exploratory, and the small sample size (50 CFS cases) limits generalizability. Replication in larger, well-characterized populations is essential before clinical application.